//////////////////////WELCOME///////////////////////////////////////
CPAP Supplies Plus/Direct Newsletter -where you will find information on the
latest sleep products and articles on Obstructive Sleep Apnea. We hope that
this information is helpful and informative. If you have any questions about
anything mentioned in this newsletter or with CPAP in general, please give us
a call, toll free, at 877-791-3195 and we will be glad to help.
Come visit us at http://www.cpapplus.com
///////////////////////////////////////////NEW PRODUCT INFORMATION///////////////////////
In case you missed our short message alerts we sent out during the month, we
would like to recap the most recent products to have come out on the market
NEW!!!
The Probasics Zzz-Pap has been very popular since the product was released a
few weeks ago. This very small CPAP machine is available with humidifier and
priced at only $240.
http://www.cpapplus.com/Machines/CPAP/Probasics/7501Machine.htm
Respironics has released their overstock of the Remstar Plus CPAP machine.
This unit has been considered the industry standard for years and will be available
for a limited time (while supplies last).
http://www.cpapplus.com/Machines/CPAP/Remstar_Plus/Remstar_Plus.html
Respironics’ Remstar Auto with AFLEX has continued to provide comfort
in CPAP therapy. AFLEX Technology allows comfort in breathing while receiving
the optimum in therapy. Read more about AFLEX at:
http://www.cpapplus.com/Machines/Auto/M_Series_Auto/M_Series_Auto.htm
Headgear AND Chinstraps!
One of the most overlooked aspects of your CPAP therapy is your headgear. This
item must be comfortable, lightweight, and cost-efficient. Tiara Medical Systems
continues to provide the CPAP community with cost effective alternatives to
products distributed by the major manufacturers.
Tiara Chin Strap:
http://www.cpapplus.com/CPAP_Headgear/Tiara_Medical/TMS-12.htm
Respironics Style Chin Strap:
http://www.cpapplus.com/CPAP_Headgear/Tiara_Medical/TMS-14.htm
Tiara Headgear: (Similar to the Simple Strap Headgear from Respironics-1”
Straps
http://www.cpapplus.com/CPAP_Headgear/Tiara_Medical/TMS-77.html
Tiara Headgear: (Similar to the Simple Strap Headgear from Respironics-3/4”
Straps
http://www.cpapplus.com/CPAP_Headgear/Tiara_Medical/TMS-78.html
CPAP Tubing!
http://www.cpapplus.com/CPAP_Tubing/Grey_Tubing/Grey_Tubing.html
CPAP Filters!
http://www.cpapplus.com/CPAP_Filters/Cross_Ref.html
/////////////////////////////////////////////HEALTH INFORMATION///////////////////////////////////////
More Evidence for OSA-Heart Disease Link
Add a study from Greece to the mountain of evidence linking CPAP therapy to
better heart function. The latest study, published online by CHEST, the journal
of the American College of Chest Physicians, concludes that CPAP therapy for
OSA patients creates measurable positive effects on serum cardiovascular risk
factors. The study by Greek physicians examined the blood of 53 newly diagnosed
OSA patients who had not yet begun CPAP therapy.
The patients (47 male, 6 female) were nonsmokers who did not have other diseases and did not take medications for other conditions. The researchers found that the serum levels of cardiovascular risk factors (hs-CRP, homocysteine, total cholesterol, triglycerides, HDL-C, LDL-C, apolipoprotein A-I, and apolipoprotein B) were elevated in the patients before CPAP therapy began. Once the patients started CPAP therapy, they were grouped by their compliance in wearing the CPAP device at night. Group 1 had good compliance—wearing the CPAP device more than 4 hours per night. Group 2 had poor compliance and wore the device less than 4 hours per night. Group 3 refused therapy completely.
After 6 months, the researchers again looked at the patients’ blood. They found that in group 1 (those with good compliance), the serum levels of cardiovascular risk factors showed a significant decrease in hs-CRP (P=0.03), homocysteine (P=0.005), total cholesterol (P=0.021), total cholesterol/HDL-C ratio (P=0.018), and apolipoprotein B/apolipoprotein A-I ratio (P=0.021). Group 2 (those with poor compliance) only had a decrease in homocysteine levels (P=0.021), while in group 3 (the patients that refused therapy), there was no significant change in the serum levels of cardiovascular risk factors.
The Greek researchers concluded that CPAP therapy may therefore reduce the
risk of cardiovascular problems. More good news for those who sell CPAP units,
and an added reason to get increased numbers diagnosed and treated for SDB.
Article appeared in HME Today Friday Report for Online News 07/06/07.
/////////////////////////////////////////////INDUSTRY NEWS///////////////////////////////////////
Ron Richards of the ResMed Corporation has resigned and taken another position.
Mr. Richards has been responsible for tremendous increases in sales and profit
for the ResMed Corp. and is now expected to create the same success for the
SeQual Corp.
http://www.freshnews.com/news/tech-people-move/article_38875.html
////////////////////////////////////////////////////////////////////
As always we hope that you find this information helpful and informative. We
thank you for choosing CPAP Supplies Plus/Direct as your supplier for CPAP equipment
and accessories.
////////////////////////////////////////////////////////////////////
You are receiving this email because you have signed up to receive information
about CPAP therapy on our website. If you wish to be removed from our mailing
list, please email remove@cpapplus.com with your email address in the subject
line of the email. Since this is an automated removal system, all requests that
do not contain the email address within the subject of the email will be ignored.
Please do not send requests for information to this email address. Please send
all requests for product information to info@cpapplus.com. Thank you.